Imexpharm

Imexpharm FCF CAGR 5Y

The FCF CAGR (5 Year) of Imexpharm (IMP.VN) as of Oct 26, 2026 is 10.55 %.

FCF CAGR 5Y

10.55 %

Last updated:

FCF CAGR (5 Year) of Imexpharm is 2025 10.55 % . FCF CAGR (5 Year) of Imexpharm was 2024 - . It decreases by % lower compared to the previous year.

The Imexpharm FCF CAGR 5Y history

The Imexpharm FCF CAGR 5Y history
YEARFCF CAGR 5YYoY
10.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

FCF CAGR (5 Year) of Imexpharm is 10.55 % in 2025.

On Eulerpool you can find the complete historical development of FCF CAGR (5 Year) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

The 5-year FCF CAGR shows the compound annual growth rate of free cash flow over five years.

To evaluate FCF CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF CAGR (5 Year).

FCF CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track FCF CAGR (5 Year)'s Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Imexpharm

All Key Metrics — Imexpharm